nach oben

Erschienen in:

01.02.2008 | Professional Issues

Psychiatric Disorders in Clinical Genetics II: Individualizing Recurrence Risks

verfasst von: Jehannine C. Austin, Christina G. S. Palmer, Beth Rosen-Sheidley, Patricia McCarthy Veach, Elizabeth Gettig, Holly L. Peay

Erschienen in: Journal of Genetic Counseling | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

This is the second article of a two-part professional development series on genetic counseling for personal and family histories of psychiatric disorders. It is based on an Educational Breakout Session presented by The Psychiatric Special Interest Group of the National Society of Genetic Counselors at the 2006 Annual Education Conference. While the first article in this two part series dealt with addressing family histories of psychiatric disorders in clinical practice, the following discussion deals with the generation and provision of individualized recurrence risks for psychiatric disorders, based on empiric risk data. We present four cases that illustrate important components of and process for generating individualized risk assessment for family histories of psychiatric disorders.

In this paper, we chose to use the geneclinics definition of recurrence risk: The likelihood that a trait or disorder present in one family member will occur again in other family members in the same or subsequent generations.

Aleman, A., Kahn, R. S., & Selten, J.-P. (2003). Sex differences in the risk of schizophrenia: Evidence from a meta-analysis. Archives of General Psychiatry, 60, 565–571.PubMedCrossRef

American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association.

an der Heiden, W., & Hafner, H. (2000). The epidemiology of onset and course of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 250, 292–303.CrossRef

Andreasen, N. C., Rice, J., Endicott, J., Reich, T., & Coryell, W. (1986). The family history approach to diagnosis. How useful is it. Archives of General Psychiatry, 43, 421–429.PubMed

Antshel, K. M., Kates, W. R., Roizen, N., Fremont, W., & Shprintzen, R. J. (2005). 22q11.2 Deletion syndrome: Genetics, neuroanatomy and cognitive/behavioural features. Child Neuropsychology, 11(1), 5–19.PubMedCrossRef

Asarnow, R. F., Nuechterlein, K. H., Fogelson, D., Subotnik, K. L., Payne, D. A., & Russell, A. T., et al. (2001). Schizophrenia and schizophrenia spectrum personality disorders in the first-degree relatives of children with schizophrenia: The UCLA family study. Archives of General Psychiatry, 58, 581–588.PubMedCrossRef

Austin, J. C., & Peay, H. L. (2006). Applications and limitations of empiric data in provision of recurrence risks for schizophrenia: A practical review for healthcare professionals providing clinical psychiatric genetics consultations. Clinical Genetics, 70(3), 177–187.PubMedCrossRef

Bassett, A. S., & Chow, E. W. C. (1999). 22q11 deletion syndrome: A genetic subtype of schizophrenia. Biological Psychiatry, 46, 882–891.PubMedCrossRef

Craig, E. A. (2004). Parenting programs for women with mental illness who have young children: A review. Australian and New Zealand Journal of Psychiatry, 38, 923–928.PubMedCrossRef

Degenhardt, L., Hall, W., & Lynskey, M. (2003). Testing hypotheses about the relationship between cannabis use and psychosis. Drug and Alcohol Dependence, 71, 37–48.PubMedCrossRef

Faraone, S. V., Tsuang, M. T., & Tsuang, D. W. (1999). Genetics of mental disorders. New York: Guildford.

Finkler, K., Skrzynia, C., & Evans, J. P. (2003). The new genetics and its consequences for family, kinship, medicine and medical genetics. Social Science & Medicine, 57, 403–412.CrossRef

Finn, C. T., & Smoller, J. W. (2006). Genetic counseling in psychiatry. Harvard Review of Psychiatry, 14, 109–121.PubMedCrossRef

Gispen-de Wied, C. (2000). Stress in schizophrenia: An integrative view. European Journal of Pharmacology, 405, 375–384.PubMedCrossRef

Goodwin, F. K., & Jamison, K. R. (1990). Manic-depressive illness. New York: Oxford University Press.

Harper, P. S. (1998). Practical genetic counselling. Oxford: Butterworth-Heinemann.

Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., & Wittchen, H.-U., et al. (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal, 330, 11.PubMedCrossRef

Hodgkinson, K. A., Murphy, J., O’Neill, S., Brzustowicz, L., & Bassett, A. S. (2001). Genetic Counseling for schizophrenia in the era of molecular genetics. Canadian Journal of Psychiatry, 46, 123–130.

Husted, J. A., Greenwood, C. M., & Bassett, A. S. (2005). Heritability of schizophrenia and major affective disorder as a function of age in the presence of strong cohort effects. European Archives of Psychiatry and Clinical Neuroscience, 356, 222–229.

Jolin, E. M., Weller, E. B., & Weller, R. A. (2006). Velocardiofacial syndrome: Is there a neuropsychiatric phenotype. Current Psychiatry Reports, 8, 96–101.PubMedCrossRef

Kay, D. (1978). Assessment of familial risks in the functional psychoses and their application in genetic counseling. British Journal of Psychiatry, 133, 385–403.PubMedCrossRef

Kendler, K. S., & Gardner, C. O. (1997). The risk for psychiatric disorders in relatives of schizophrenic and control probands: A comparison of three independent studies. Psychologie in der Medizin, 27(2), 411–419.CrossRef

Laursen, T. M., Labouriau, R., Licht, R. W., Bertelsen, A., Munk-Olsen, T., & Mortensen, P. B. (2005). Family history of psychiatric illness as a risk factor for schizoaffective disorder. Archives of General Psychiatry, 62, 841–848.PubMedCrossRef

Lee, L. C., Halpern, C. T., Hertz-Picciotto, I., Martin, S. L., & Suchundran, C. M. (2006). Child care and social support modify the association between maternal depressive symptoms and early childhood behavior problems: A US national study. Journal of Epidemiology and Community Health, 60, 305–310.PubMedCrossRef

McCarthy Veach, P., LeRoy, B. S., & Bartels, D. M. (2003). Facilitating the genetic counseling process: A practice manual. New York: Springer.

McGorry, P. D., & Killackey, E. J. (2002). Early Intervention in psychosis: a new evidence based paradigm. Epidemiologia E Psichiatria Sociale, 11(4), 237–247.PubMed

McGorry, P. D., & Singh, B. S. (1995). In B. Raphael, & G. D. Burrows (Eds.) Schizophrenia: Risk and possibility. Handbook of preventive psychiatry pp. 492–514. Amsterdam: Elsevier.

McGorry, P. D., & Yung, A. R. (2003). Early intervention in psychosis: an overdue reform. Australian and New Zealand Journal of Psychiatry, 37(4), 393–398.PubMedCrossRef

McGrath, J., Saha, S., Welham, J., El Saadi, O., MacCauley, C., & Chant, D. (2004). A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine, 2, 13.PubMedCrossRef

McGuire, P. K., Jones, P., Harvey, I., Williams, M., McGuffin, P., & Murray, R. M. (1995). Morbid risk of schizophrenia for relatives of patients with cannabis associated psychosis. Schizophrenia Research, 15, 277–281.PubMedCrossRef

Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M., & Petukhova, M., et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Archives of General Psychiatry, 64, 543–552.PubMedCrossRef

Mikami, T., Naruse, N., Fukura, Y., Ohkubo, H., Ohkubo, T., & Matsuura, M., et al. (2003). Determining vulnerability to schizophrenia in methamphetamine psychosis using exploratory eye movements. Psychiatry and Clinical Neurosciences, 57(4), 433–440.PubMedCrossRef

Morrison, A. P., French, P., Walford, L., Lewis, S. W., Kilcommons, A., & Green, J., et al. (2004). Cognitive therapy for the prevention of psychosis in people at ultra-high risk. British Journal of Psychiatry, 185, 291–297.PubMedCrossRef

Nicolson, R., Brookner, F. B., Lenane, M., Gochman, P., Ingraham, L. J., & Egan, M. F., et al. (2003). Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. American Journal of Psychiatry, 160(3), 490–495.PubMedCrossRef

Nurnberger, J. L., & Berrettini, W. (1998). Psychiatric genetics. London: Chapman and Hall.

Organization, W. H. (1992). The ICD-10 Classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: WHO.

Ott, J. (1999). Analysis of human genetic linkage. Baltimore: Johns Hopkins University Press.

Quaid, K. A., Aschen, S. R., Smiley, C. L., & Nurnberger, J. I. (2001). Perceived genetic risks for bipolar disorder in a patient population: An exploratory study. Journal of Genetic Counseling, 10, 41–51.CrossRef

Ritvo, E. R., Jorde, L. B., Mason-Brothers, A., Freeman, B. J., Pingree Jones, M. B., & McMahon, W. M., et al. (1989). The UCLA-University of Utah epidemiologic survey of autism: Recurrence risk estimates and genetic counseling. American Journal of Psychiatry, 146, 1032–1036.PubMed

Ross, R. G., Olincy, A., Harris, J. G., Radant, A., Hawkins, M., & Adler, L. E., et al. (1999). Evidence for bilineal inheritance of physiological indicatios of risk in childhood onset schizophrenia. American Journal of Medical Genetics, 88(2), 188–199.PubMedCrossRef

Siklos, S., & Kerns, K. A. (2007). Assessing the diagnostic experiences of a small sample of parents and children with autism spectrum disorders. Research in Developmental Disabilities, 28(1), 9–22.PubMedCrossRef

Simonoff, E. (1998). Genetic counseling in Autism and pervasive developmental disorders. Journal of Autism and Developmental Disorders, 28(5), 447–456.PubMedCrossRef

Smoller, J. W., & Finn, C. T. (2003). Family, twin and adoption studies of bipolar disorder. American Journal of Medical Genetics, 123C, 48–58.CrossRefPubMed

Solomon, M., Hessl, D., Chiu, S., Hagerman, R., & Hendren, R. (2007). A genetic etiology of pervasive developmental disorder guides treatment. American Journal of Psychiatry, 164(4), 575–580.PubMedCrossRef

Thoppil, J., Riutcel, T. L., & Nalesnik, S. W. (2005). Early intervention for perinatal depression. American Journal of Obstetrics and Gynecology, 192, 1446–1448.PubMedCrossRef

Tsiouris, J., & Brown, W. (2004). Neuropsychiatric symptoms of fragile X syndrome. CNS Drugs, 18(11), 687–703.PubMedCrossRef

Umlauf, M. G., & Shattel, M. (2005). The ecology of bipolar disorder: the importance of sleep. Issues in Mental Health Nursing, 26, 699–720.PubMedCrossRef

van Os, J., Bak, M., Hanssen, M., Bijl, R. V., de Graaf, R., & Verdoux, H. (2002). Cannabis use and psychosis: A longitudinal population-based study. American Journal of Epidemiology, 156(4), 319–327.PubMedCrossRef

Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S. M., McFarlane, C. A., & Hallgren, M., et al. (2003). Psychosis prediction: 12-month follow up of a high-risk (prodromal) group. Schizophrenia Research, 60, 21–32.PubMedCrossRef

Yung, A. R., Phillips, L. J., Yuen, H. P., & McGorry, P. D. (2004). Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophrenia Research, 67, 131–142.PubMedCrossRef

Titel: Psychiatric Disorders in Clinical Genetics II: Individualizing Recurrence Risks
verfasst von: Jehannine C. Austin
Christina G. S. Palmer
Beth Rosen-Sheidley
Patricia McCarthy Veach
Elizabeth Gettig
Holly L. Peay
Publikationsdatum: 01.02.2008
Verlag: Springer US
Erschienen in: Journal of Genetic Counseling / Ausgabe 1/2008
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-007-9121-4

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2008

“Are You at Risk for Hereditary Breast Cancer?”: Development of a Personal Risk Assessment Tool for Hereditary Breast and Ovarian Cancer

How Risk is Perceived, Constructed and Interpreted by Clients in Clinical Genetics, and the Effects on Decision Making: Systematic Review

Living at Risk: Concealing Risk and Preserving Hope in Huntington Disease

Psychiatric Disorders in Clinical Genetics I: Addressing Family Histories of Psychiatric Illness